Health Services Insights · 2023 · 12 citations · 16 references
MedicineChild HealthInfectious DiseasesEpidemiologyImmunizationVaccinologyImmunization PracticeVaccinationVaccination PolicyVaccine PolicyVaccine Scale-upVaccine-preventable DiseasesCovid-19 Vaccination PolicyInductive Thematic AnalysisKey Informant InterviewsPneumococcal Conjugate VaccinationPneumococcal Conjugate VaccinesQualitative Data CollectionVaccination Uptake BarriersVaccine Access Barriers
Background: Pneumonia is one of the leading causes of death in under-5 children in India. This led the Ministry of Health & Family Welfare (MoHFW) in India to decide for the nationwide roll-out of the Pneumococcal Conjugate Vaccine (PCV). However, the introduction of PCV became more complex in the face of unprecedented challenges set forth by the COVID-19 pandemic. The study aims to assess enablers and barriers to the introduction of PCV in India during the pandemic. Methodology: Qualitative research approach involving key-informant interviews from John Snow India (JSI), the lead technical agency that supported MoHFW in the PCV expansion was employed to delineate the enablers and barriers. Principle of saturation was employed to derive the sample size. Thematic analysis using inductive approach was based on the modified World Health Organization (WHO) framework for new vaccine introduction impact on the Immunization and Health Systems, using NVIVO 12 qualitative data analysis software. Results: A total of 11 key informants (4 national-level program managers and 7 state technical officers) were telephonically interviewed. The study found social acceptance, lower cost of the vaccine, and intensive communication activities as potential enablers. Other enablers for PCV introduction included a robust vaccine supply-chain system, ample cold-chain space availability, and strong political commitment, despite the ongoing second wave. Further, the identified barriers included poor physical access, insufficient social mobilization, and limited advocacy along with a stretched workforce. Conclusion: The study delineated several enablers and barriers to introducing PCV in the country during the pandemic. The existing barriers in the PCV roll-out prompted the need to address these gaps, making key program-based recommendations to improve future new vaccine introductions during the pandemic.
16
Jeanne M. Santoli, Megan C. Lindley, Malini B. DeSilva et al. · MMWR Morbidity and Mortality Weekly Report · 2020 · 718 citations · Full text
COVID-19 disrupts vaccine delivery
Roxanne Nelson · The Lancet Infectious Diseases · 2020 · 198 citations · Full text
Rebecca C. Harris, Yutao Chen, Pierre Côté et al. · The Lancet Regional Health - Western Pacific · 2021 · 173 citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17